Gainers
- Genprex, Inc. GNPX jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
- Celyad SA CYAD shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
- DMC Global Inc. BOOM shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
- eHealth, Inc. EHTH gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
- Enova International, Inc. ENVA climbed 20.4 percent to $27.20 following Q1 results.
- SVB Financial Group SIVB shares jumped 18.2 percent to $304.135 following strong quarterly results.
- Knowles Corporation KN gained 13.9 percent to $12.70 as the company reported Q1 results.
- Zymeworks Inc. ZYME gained 13.8 percent to $17.36.
- Cocrystal Pharma, Inc. COCP rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
- ImmunoGen, Inc. IMGN shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
- Eloxx Pharmaceuticals, Inc. ELOX gained 9.5 percent to $12.70.
- Expedia Group, Inc. EXPE shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
- Sprint Corporation S shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-Mobile Us Inc TMUS are proceeding and could even be completed "as early as next week." The report cautioned "there is no certainty that a deal will be reached."
- Brinker International, Inc. EAT gained 5.8 percent to $43.75. RBC Capital upgraded Brinker from Sector Perform to Outperform.
- Amazon.com, Inc. AMZN rose 4.9 percent to $1,590.69 after the company posted upbeat results for its first quarter. The company sees second quarter operating income of $1.1 billion - $1.9 billion and sales of $51 billion - $54 billion.
- Baidu, Inc. BIDU rose 4.6 percent to $249.75 following upbeat Q1 profit.
Check out these big penny stock gainers and losers
Losers
- World Fuel Services Corporation INT tumbled 18 percent to $22.90 following Q1 results.
- Biglari Holdings Inc. BH fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
- Flex Ltd. FLEX dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
- FormFactor, Inc. FORM fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
- Data I/O Corporation DAIO dropped 14.3 percent to $6.24 following Q1 results.
- National Instruments Corporation NATI fell 14.3 percent to $ 42.34 after reporting Q1 results.
- United States Steel Corporation X dipped 14.2 percent to $32.37 following Q1 results.
- Civeo Corporation CVEO dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
- athenahealth, Inc. ATHN fell 12.4 percent to $125.310 after reporting Q1 results.
- Charter Communications, Inc. CHTR shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
- Value Line, Inc. VALU fell 11.3 percent to $19.10.
- Federated Investors, Inc. FII shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
- AV Homes, Inc. AVHI declined 10.7 percent to $17.20 following Q1 results.
- CalAmp Corp. CAMP dropped 9.4 percent to $21.01 after reporting Q4 results.
- Tandem Diabetes Care, Inc. TNDM shares fell 8.9 percent to $7.280 following mixed Q1 results.
- Sony Corporation SNE shares fell 8.4 percent to $45.97 after reporting Q4 results.
- LogMeIn Inc LOGM fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
- Eleven Biotherapeutics, Inc. EBIO fell 7.7 percent to $2.17.
- ATN International, Inc. ATNI dropped 7.2 percent to $56.7825. BWS Financial downgraded ATN International from Hold to Sell.
ATNIATN International Inc
$16.54-%
AVHIAchari Ventures Holdings Corp I Ordinary Shares
$11.512.77%
BHBiglari Holdings Inc
$262.92-0.62%
BIDUBaidu Inc
$88.320.31%
BOOMDMC Global Inc
$6.901.17%
CAMPCamp4 Therapeutics Corp
$7.589.86%
CHTRCharter Communications Inc
$351.78-0.12%
COCPCocrystal Pharma Inc
$2.540.79%
CVEOCiveo Corp
$21.10-4.48%
DAIOData I/O Corp
$2.832.17%
EATBrinker International Inc
$137.00-0.14%
EHTHeHealth Inc
$8.768.96%
ELOXEloxx Pharmaceuticals Inc
$0.000001-100.0%
ENVAEnova International Inc
$99.610.98%
EXPEExpedia Group Inc
$190.120.23%
FLEXFlex Ltd
$39.731.48%
FORMFormFactor Inc
$47.10-1.46%
GNPXGenprex Inc
$0.9063-2.36%
KNKnowles Corp
$20.181.36%
SSentinelOne Inc
$22.991.32%
TMUST-Mobile US Inc
$223.500.22%
TNDMTandem Diabetes Care Inc
$37.641.72%
VALUValue Line Inc
$54.100.90%
XUnited States Steel Corp
$31.35-1.94%
ZYMEZymeworks Inc
$14.502.55%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in